Please use this identifier to cite or link to this item:
|Title:||Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model||Authors:||Bard-Chapeau, E.A.
De Jong, J.
|Issue Date:||Jan-2014||Citation:||Bard-Chapeau, E.A., Nguyen, A.-T., Rust, A.G., Sayadi, A., Lee, P., Chua, B.Q., New, L.-S., De Jong, J., Ward, J.M., Chin, C.K.Y., Chew, V., Toh, H.C., Abastado, J.-P., Benoukraf, T., Soong, R., Bard, F.A., Dupuy, A.J., Johnson, R.L., Radda, G.K., Chan, E.C.Y., Wessels, L.F.A., Adams, D.J., Jenkins, N.A., Copeland, N.G. (2014-01). Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model. Nature Genetics 46 (1) : 24-32. ScholarBank@NUS Repository. https://doi.org/10.1038/ng.2847||Abstract:||The most common risk factor for developing hepatocellular carcinoma (HCC) is chronic infection with hepatitis B virus (HBV). To better understand the evolutionary forces driving HCC, we performed a near-saturating transposon mutagenesis screen in a mouse HBV model of HCC. This screen identified 21 candidate early stage drivers and a very large number (2,860) of candidate later stage drivers that were enriched for genes that are mutated, deregulated or functioning in signaling pathways important for human HCC, with a striking 1,199 genes being linked to cellular metabolic processes. Our study provides a comprehensive overview of the genetic landscape of HCC. © 2014 Nature America, Inc.||Source Title:||Nature Genetics||URI:||http://scholarbank.nus.edu.sg/handle/10635/116010||ISSN:||10614036||DOI:||10.1038/ng.2847|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.